Search Results - "Arthur, Kenisha"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Robust detection of oncometabolic aberrations by 1H–13C heteronuclear single quantum correlation in intact biological specimens by Barekatain, Yasaman, Yan, Victoria C., Arthur, Kenisha, Ackroyd, Jeffrey J., Khadka, Sunada, De Groot, John, Huse, Jason T., Muller, Florian L.

    Published in Communications biology (25-06-2020)
    “…Magnetic resonance (MR) spectroscopy has potential to non-invasively detect metabolites of diagnostic significance for precision oncology. Yet, many…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Aliphatic amines are viable pro-drug moieties in phosphonoamidate drugs by Yan, Victoria C., Pham, Cong-Dat, Arthur, Kenisha, Yang, Kristine L., Muller, Florian L.

    Published in Bioorganic & medicinal chemistry letters (15-12-2020)
    “…[Display omitted] Phosphate and phosphonates containing a single PN bond are frequently used pro-drug motifs to improve cell permeability of these otherwise…”
    Get full text
    Journal Article
  7. 7

    Abstract 984: Synthesis of mixed, hypoxia-activated phosphoramidate esters for the inhibition of Enolase in ENO1- deleted glioblastoma by Muller, Florian, Yan, Victoria C., Ballato, Elliot S., Yang, Kristine L., Georgiou, Dimitra K., Arthur, Kenisha, Shrestha, Pakriti, Khadka, Sunada, Ackroyd, Jeffrey

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Background: Precision oncology is currently restricted to activated oncogenes as drug targets, with tumor suppressor deletions remaining largely…”
    Get full text
    Journal Article
  8. 8

    TAMI-62. ANGIOGENESIS INHIBITORS STRONGLY SYNERGIZE WITH THERAPEUTICS TARGETING TUMOR METABOLISM by Khadka, Sunada, Lin, Yu-Hsi, Ackroyd, Jeffrey, Arthur, Kenisha, Barekatain, Yasaman, Poral, Anton, Tran, Theresa, Georgiou, Dimitra, de Groot, John, Huse, Jason, Asara, John, Muller, Florian

    Published in Neuro-oncology (Charlottesville, Va.) (09-11-2020)
    “…Abstract Angiogenesis inhibition has become a mainstay of oncology despite having fallen short of its early promise. As originally envisioned, angiogenesis…”
    Get full text
    Journal Article
  9. 9

    Abstract 3208: Angiogenesis inhibitors strongly synergize with therapeutics targeting tumor metabolism by Khadka, Sunada, Lin, Yu-Hsi, Ackroyd, Jeffery, Arthur, Kenisha, Barekatain, Yasaman, Poral, Anton, Tran, Theresa, Behr, Eliot, Chen, Yining, Georgiou, Dimitra, Depinho, Ronald, Muller, Florian

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract Angiogenesis inhibition has become a mainstay of oncology despite having fallen short of its early promise. As originally envisioned, angiogenesis…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study by Yan, Victoria C, Yang, Kristine L, Ballato, Elliot S, Khadka, Sunada, Shrestha, Prakriti, Arthur, Kenisha, Georgiou, Dimitra K, Washington, Mykia, Tran, Theresa, Poral, Anton H, Pham, Cong-Dat, Yan, Matthew J, Muller, Florian L

    Published in ACS medicinal chemistry letters (09-07-2020)
    “…Glycolysis inhibition remains aspirational in cancer therapy. We recently described a promising phosphonate inhibitor of enolase for cancers harboring…”
    Get full text
    Journal Article
  12. 12

    Robust detection of oncometabolic aberrations by 1 H- 13 C heteronuclear single quantum correlation in intact biological specimens by Barekatain, Yasaman, Yan, Victoria C, Arthur, Kenisha, Ackroyd, Jeffrey J, Khadka, Sunada, De Groot, John, Huse, Jason T, Muller, Florian L

    Published in Communications biology (25-06-2020)
    “…Magnetic resonance (MR) spectroscopy has potential to non-invasively detect metabolites of diagnostic significance for precision oncology. Yet, many…”
    Get full text
    Journal Article
  13. 13